Raden Danarto1, Indwiani Astuti2, Rainy Umbas3, Sofia Mubarika Haryana4. 1. Department of Surgery, Universitas Gadjah Mada School of Medicine, Yogyakarta, Indonesia. 2. Department of Pharmacology, Universitas Gadjah Mada School of Medicine, Yogyakarta, Indonesia. 3. Department of Urology, Universitas Indonesia School of Medicine, Jakarta, Indonesia. 4. Postgraduate Doctoral Program, Universitas Gadjah Mada School of Medicine, Yogyakarta, Indonesia.
Abstract
OBJECTIVE: To evaluate the miR-21-5p and miR-200c-3p expressions in the urine of patients with prostate cancer (PCa) and to investigate their potential as biomarkers. MATERIAL AND METHODS: The urine samples collected from 80 patients, including 20 patients diagnosed with benign prostate hyperplasia (BPH) and 60 patients diagnosed with PCa, were examined. The exosome isolation was performed using the miRCURY exosome isolation kit (Exiqon, Denmark), total RNA was extracted using the miRCURY RNA Isolation Kit-Biofluid kit (Exiqon, Denmark), and complementary DNA (cDNA) was synthesized using the Universal cDNA Synthesis kit (Exiqon, Denmark). A quantitative polymerase chain reaction (qPCR) analysis of gene expression was performed using the qPCR CFX 96 Thermocycler (Bio-Rad). All the procedures followed the manufacturer's recommendations. RESULTS: The overexpressions of miR-21 in the non-metastatic PCa and metastatic PCa group compared to the BPH group were statistically significant with a p-value of 0.001 and 0.018, respectively. The non-metastatic PCa compared to the metastatic PCa group was also statistically significant with a p-value of 0.037. The under expressions of miR-200c in the non-metastatic PCa and metastatic PCa group compared to the BPH group are statistically significant with a p-value of 0.001 and 0.001, respectively. CONCLUSION: The overexpressions of miR-21 found in this study could be a potential non-invasive diagnostic tool for patients with PCa. Despite the significant results in our study, the use of micro-RNA in urine samples may vary due to epigenetic variation. Further studies with larger populations are required to investigate the role of miR-21 and miR-200c as biomarkers in PCa.
OBJECTIVE: To evaluate the miR-21-5p and miR-200c-3p expressions in the urine of patients with prostate cancer (PCa) and to investigate their potential as biomarkers. MATERIAL AND METHODS: The urine samples collected from 80 patients, including 20 patients diagnosed with benign prostate hyperplasia (BPH) and 60 patients diagnosed with PCa, were examined. The exosome isolation was performed using the miRCURY exosome isolation kit (Exiqon, Denmark), total RNA was extracted using the miRCURY RNA Isolation Kit-Biofluid kit (Exiqon, Denmark), and complementary DNA (cDNA) was synthesized using the Universal cDNA Synthesis kit (Exiqon, Denmark). A quantitative polymerase chain reaction (qPCR) analysis of gene expression was performed using the qPCR CFX 96 Thermocycler (Bio-Rad). All the procedures followed the manufacturer's recommendations. RESULTS: The overexpressions of miR-21 in the non-metastatic PCa and metastatic PCa group compared to the BPH group were statistically significant with a p-value of 0.001 and 0.018, respectively. The non-metastatic PCa compared to the metastatic PCa group was also statistically significant with a p-value of 0.037. The under expressions of miR-200c in the non-metastatic PCa and metastatic PCa group compared to the BPH group are statistically significant with a p-value of 0.001 and 0.001, respectively. CONCLUSION: The overexpressions of miR-21 found in this study could be a potential non-invasive diagnostic tool for patients with PCa. Despite the significant results in our study, the use of micro-RNA in urine samples may vary due to epigenetic variation. Further studies with larger populations are required to investigate the role of miR-21 and miR-200c as biomarkers in PCa.
Authors: Raffaele Baffa; Matteo Fassan; Stefano Volinia; Brian O'Hara; Chang-Gong Liu; Juan P Palazzo; Marina Gardiman; Massimo Rugge; Leonard G Gomella; Carlo M Croce; Anne Rosenberg Journal: J Pathol Date: 2009-10 Impact factor: 7.996
Authors: D Bonci; V Coppola; M Patrizii; A Addario; A Cannistraci; F Francescangeli; R Pecci; G Muto; D Collura; R Bedini; A Zeuner; M Valtieri; S Sentinelli; M S Benassi; M Gallucci; P Carlini; S Piccolo; R De Maria Journal: Oncogene Date: 2015-06-15 Impact factor: 9.867
Authors: Jovito Cesar Santos-Álvarez; Juan Manuel Velázquez-Enríquez; Rosendo García-Carrillo; César Rodríguez-Beas; Alma Aurora Ramírez-Hernández; Edilburga Reyes-Jiménez; Karina González-García; Armando López-Martínez; Laura Pérez-Campos Mayoral; Sergio Roberto Aguilar-Ruiz; María de Los Ángeles Romero-Tlalolini; Honorio Torres-Aguilar; Luis Castro-Sánchez; Jaime Arellanes-Robledo; Verónica Rocío Vásquez-Garzón; Rafael Baltiérrez-Hoyos Journal: Cells Date: 2022-03-25 Impact factor: 6.600